DTC Future: Firms Could Pool Dollars For Educational Spots; “Got Drugs?”
Executive Summary
Pharmaceutical companies should devote more of their advertising budgets to collective disease education efforts, Rx Insight CEO Bob Ehrlich said
You may also be interested in...
Patient Retention Ads Should Be Larger Part Of DTC Spend, Consultant Says
Pharmaceutical companies should devote more of their advertising budgets to patient retention and compliance, DTC Perspectives CEO Robert Ehrlich said
Patient Retention Ads Should Be Larger Part Of DTC Spend, Consultant Says
Pharmaceutical companies should devote more of their advertising budgets to patient retention and compliance, DTC Perspectives CEO Robert Ehrlich said
DTC And FDA: “Brief Summary” Improvements Are Priority For McClellan
FDA will address physicians' "legitimate" concern that direct-to-consumer ads do not provide balanced risk-benefit information, Commissioner McClellan told the National Association of Health Underwriters legislative conference March 25 in Washington, D.C